Horizontal Transfer of miR-643 from Cisplatin-Resistant Cells Confers Chemoresistance to Recipient Drug-Sensitive Cells by Targeting APOL6

Acquisition of resistance to cisplatin is a major impediment to the success of cisplatin-based combination therapies for cancer. Recent studies indicate that exosomal miRNAs derived from drug-resistant tumour cells can confer resistance properties to recipient cells by a horizontal transfer mechanis...

詳細記述

書誌詳細

出版年:	Cells
主要な著者:	Grace R. Raji, Aswini Poyyakkara, Anjali Kunhi Krishnan, Ashutosh Kumar Maurya, Udeshna Changmai, Sharath S. Shankar, V. B. Sameer Kumar
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2021-05-01
主題:	cisplatin resistance exosomes miR-643 APOL6 apoptosis
オンライン･アクセス:	https://www.mdpi.com/2073-4409/10/6/1341